The efficacy of GDATA in diagnosing early HCC was compared with the internationally recognized HCC screening and diagnosis model GALAD and serum markers GPC3, AFP, AFP-L3% and DCP (as shown in Figure 4). This evidence concerns the gene AFP and hepatocellular carcinoma.